Evaluate the Safety and Efficacy of BLEX 404 Oral Liquid Combined With Pemetrexed + Cisplatin Therapy

NCT05764928 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Nonsquamous Nonsmall Cell Neoplasm of Lung

Interventions

DRUG: BLEX 404

Sponsor

Rgene Corporation

Collaborators

[object Object]